PhotoDerm PL

PhotoDerm ® PL

Dermatology An electro-optic device for noninvasive treatment of benign pigmented lesions–eg, age/liver spots, freckles, birthmarks, melasma, hyperpigmentation, tattoos using intense pulsed light
References in periodicals archive ?
The Company's current products include the PhotoDerm VL for benign vascular lesions and the PhotoDerm PL for pigmented lesions and tattoos, the Topaz(TM) 30, the NovaPulse laser and the LX 20 laser for general dermatological and skin resurfacing applications, all of which have been cleared by the FDA for marketing in the U.
Nasdaq:ESCMF) today announced that it has received clearance from the US Food and Drug Administration (FDA) to market the PhotoDerm PL in the United States.
PhotoDerm PL will be offered as a stand-alone device or as an add-on to PhotoDerm VL.
Shimon Eckhouse, President and Chief Executive Officer, commented, We are very pleased with the FDA s clearance to market PhotoDerm PL in the United States.
The Company's current products include the PhotoDerm(R)VL for benign vascular lesions and the PhotoDerm PL for pigmented lesions and tattoos, as well as the Topaz 30, the NovaPulse laser and the LX 20 laser for general dermatological and skin resurfacing applications, all of which have been cleared by the FDA for marketing in the U.
The PhotoDerm PL, a system for the non invasive treatment of benign pigmented lesions and tattoos which we filed with the Food and Drug Administration (FDA) for marketing clearance in February 1996, is currently being sold in several international markets.
This declaration means that the PhotoDerm VL, PhotoDerm PL, PhotoDerm VL/PL, EpiLight and the VersaLight are qualified for CE in compliance with the Medical Device Directive a3/42/EEC.
PhotoDerm PL is an intense pulsed light source, similar to but not the same as a laser.
A key benefit of PhotoDerm PL is its ability to treat pigmented spots and multicolored tattoos with fewer adverse effects that other methods of treatment, such as traditional lasers, surgery or bleaching agents.
The advent of PhotoDerm PL provides a safe and effective way to treat the broad range of epidermal pigmented lesions," says Mark Taylor, MD, a dermatologic surgeon in Salt Lake City, Utah, who tested the device in clinical trials.
PhotoDerm PL uses thermal energy generated by a broad spectrum of pulsed light waves which is absorbed by the pigment (e.
The clinical success of PhotoDerm PL is largely attributed to its flexible treatment parameters, which can be adjusted to optimally fit the color and depth of the lesion with the natural skin pigmentation of the patient.